Review




Structured Review

Novartis imatinib mesilate (glivec
Imatinib Mesilate (Glivec, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glivec/nct05009927-2-0-3?v=Novartis
Average 90 stars, based on 1 article reviews
imatinib mesilate (glivec - by Bioz Stars, 2026-06
90/100 stars

Images



Similar Products

95
MedChemExpress imatinib
Imatinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glivec/pm42035550-57-14-17?v=MedChemExpress
Average 95 stars, based on 1 article reviews
imatinib - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

90
Novartis imatinib mesilate (glivec
Imatinib Mesilate (Glivec, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glivec/nct05009927-2-0-3?v=Novartis
Average 90 stars, based on 1 article reviews
imatinib mesilate (glivec - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

86
Novartis generic imatinib
Generic Imatinib, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glivec/10__1200_slash_op___25___01096-98-22-30?v=Novartis
Average 86 stars, based on 1 article reviews
generic imatinib - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Novartis glivec
Glivec, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glivec/pm42135167-90-14-20?v=Novartis
Average 86 stars, based on 1 article reviews
glivec - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Novartis imatinib rnesylate
Imatinib Rnesylate, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glivec/us12622983-94-22-25?v=Novartis
Average 86 stars, based on 1 article reviews
imatinib rnesylate - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Ciba Geigy abl tyrosine kinase inhibitor cgp57148b
Abl Tyrosine Kinase Inhibitor Cgp57148b, supplied by Ciba Geigy, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glivec/10__1042_slash_ebc20260003-94-9-3?v=Ciba+Geigy
Average 86 stars, based on 1 article reviews
abl tyrosine kinase inhibitor cgp57148b - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Novartis gleevec
Gleevec, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glivec/us12617787-322-65-66?v=Novartis
Average 86 stars, based on 1 article reviews
gleevec - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Novartis imatinib
Cresyl violet staining of the CA1 and CA3 regions of the hippocampus (×40 magnification). A : CA1, control. Normal pyramidal neurons with well-organized and densely packed cellular architecture. B : CA3, control. Preserved neuronal morphology and normal pyramidal cell layer organization. C : CA1, ICV-STZ + saline. Reduced neuronal density and early neurodegenerative changes, including shrunken pyramidal neurons and pericellular spaces (arrows). D : CA3, ICV-STZ + saline. Marked neuronal loss, severe disruption of pyramidal layer organization, and presence of pyknotic neurons (arrows). E : CA1, ICV-STZ + <t>imatinib.</t> Increased neuronal count compared to the ICV-STZ group, with partial restoration of pyramidal neuron morphology. F : CA3, ICV-STZ + imatinib. Moderate improvement in neuronal density and morphology, although some degenerative changes persist. G : CA1, ICV-STZ + nilotinib. Increased neuronal density and improved cellular organization, approaching nearnormal morphology. H : CA3, ICV-STZ + nilotinib. Significant restoration of pyramidal layer structure with increased neuronal count and improved morphology. ICV-STZ : intracerebroventricular streptozotocin.
Imatinib, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/glivec/pmc13172787-59-6-10?v=Novartis
Average 86 stars, based on 1 article reviews
imatinib - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Cresyl violet staining of the CA1 and CA3 regions of the hippocampus (×40 magnification). A : CA1, control. Normal pyramidal neurons with well-organized and densely packed cellular architecture. B : CA3, control. Preserved neuronal morphology and normal pyramidal cell layer organization. C : CA1, ICV-STZ + saline. Reduced neuronal density and early neurodegenerative changes, including shrunken pyramidal neurons and pericellular spaces (arrows). D : CA3, ICV-STZ + saline. Marked neuronal loss, severe disruption of pyramidal layer organization, and presence of pyknotic neurons (arrows). E : CA1, ICV-STZ + imatinib. Increased neuronal count compared to the ICV-STZ group, with partial restoration of pyramidal neuron morphology. F : CA3, ICV-STZ + imatinib. Moderate improvement in neuronal density and morphology, although some degenerative changes persist. G : CA1, ICV-STZ + nilotinib. Increased neuronal density and improved cellular organization, approaching nearnormal morphology. H : CA3, ICV-STZ + nilotinib. Significant restoration of pyramidal layer structure with increased neuronal count and improved morphology. ICV-STZ : intracerebroventricular streptozotocin.

Journal: Journal of Korean Neurosurgical Society

Article Title: Comparative Evaluation of Imatinib and Nilotinib in a Streptozotocin-Induced Rat Model of Alzheimer’s Disease : Neuroprotective, Anti-inflammatory, and Cognitive Outcomes

doi: 10.3340/jkns.2025.0110

Figure Lengend Snippet: Cresyl violet staining of the CA1 and CA3 regions of the hippocampus (×40 magnification). A : CA1, control. Normal pyramidal neurons with well-organized and densely packed cellular architecture. B : CA3, control. Preserved neuronal morphology and normal pyramidal cell layer organization. C : CA1, ICV-STZ + saline. Reduced neuronal density and early neurodegenerative changes, including shrunken pyramidal neurons and pericellular spaces (arrows). D : CA3, ICV-STZ + saline. Marked neuronal loss, severe disruption of pyramidal layer organization, and presence of pyknotic neurons (arrows). E : CA1, ICV-STZ + imatinib. Increased neuronal count compared to the ICV-STZ group, with partial restoration of pyramidal neuron morphology. F : CA3, ICV-STZ + imatinib. Moderate improvement in neuronal density and morphology, although some degenerative changes persist. G : CA1, ICV-STZ + nilotinib. Increased neuronal density and improved cellular organization, approaching nearnormal morphology. H : CA3, ICV-STZ + nilotinib. Significant restoration of pyramidal layer structure with increased neuronal count and improved morphology. ICV-STZ : intracerebroventricular streptozotocin.

Article Snippet: Group 2 (n=8) received 60 mg/kg imatinib (Gleevec ® ; Novartis Pharmaceuticals, Basel, Switzerland) daily via oral gavage.

Techniques: Staining, Control, Saline, Disruption